Corcept announces pricing of $39 mill underwritten public offering
This article was originally published in Scrip
Executive Summary
Corcept Therapeutics has offered details of its planned stock sale, offering at least 10 million shares. It has priced the shares at $3.90 each, it said in an announcement 21 January.